Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5506893 | Biochemical and Biophysical Research Communications | 2016 | 8 Pages |
Abstract
Our experiment show that ZIC5 is highly upregulated in NSCLC tumor tissues and suggest that ZIC5 may act as an oncogene by influencing CCNB1 and CDK1 complex expression. ZIC5 may therefore be a potential biomarker and therapeutic target for NSCLC patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Qi Sun, Run Shi, Xin Wang, Demin Li, Haiwei Wu, Binhui Ren,